Pierre Marquet

16.8k total citations
414 papers, 11.5k citations indexed

About

Pierre Marquet is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Pierre Marquet has authored 414 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Transplantation, 70 papers in Pediatrics, Perinatology and Child Health and 67 papers in Surgery. Recurrent topics in Pierre Marquet's work include Renal Transplantation Outcomes and Treatments (170 papers), Pharmacological Effects and Toxicity Studies (59 papers) and Drug Transport and Resistance Mechanisms (37 papers). Pierre Marquet is often cited by papers focused on Renal Transplantation Outcomes and Treatments (170 papers), Pharmacological Effects and Toxicity Studies (59 papers) and Drug Transport and Resistance Mechanisms (37 papers). Pierre Marquet collaborates with scholars based in France, Switzerland and Belgium. Pierre Marquet's co-authors include Gérard Lachâtre, Annick Rousseau, Nicolas Picard, Yannick Le Meur, Jean‐Michel Gaulier, Franck Saint‐Marcoux, Jean‐Baptiste Woillard, François‐Ludovic Sauvage, Jean Debord and Aurélie Prémaud and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Pierre Marquet

397 papers receiving 11.2k citations

Peers

Countries citing papers authored by Pierre Marquet

Since Specialization

Citations

This map shows the geographic impact of Pierre Marquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Marquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Marquet more than expected).

Fields of papers citing papers by Pierre Marquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Marquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Marquet. The network helps show where Pierre Marquet may publish in the future.

Co-authorship network of co-authors of Pierre Marquet

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Marquet. A scholar is included among the top collaborators of Pierre Marquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Marquet. Pierre Marquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimation of Overall Cyclosporine Exposure Using Machine Learning 2025 ·Therapeutic Drug Monitoring ·Jean‐Baptiste Woillard, Marc Labriffe, Pierre Marquet	0
2	Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies 2025 ·Basic & Clinical Pharmacology & Toxicology ·(unknown), (unknown), (unknown), (unknown), Pierre Marquet, Jean‐Baptiste Woillard, Caroline Monchaud	0
3	A thorough clinical study pipeline to discover and validate biomarkers in kidney transplantation: The European BIOMARGIN program 2025 ·Journal of Pharmaceutical and Biomedical Analysis ·Pierre Marquet, (unknown), Dany Anglicheau, Maarten Naesens, Wilfried Gwinner, Etienne Thévenot, Marc Labriffe, Marie Essig	1
4	Optimizing CMV therapy: Population pharmacokinetics and Monte Carlo simulations for letermovir and maribavir dosage 2025 ·PLoS ONE ·(unknown), (unknown), Sophie Alain, Pierre Marquet, (unknown), Jean‐Baptiste Woillard	0
5	Revisiting the nature and pharmacodynamics of tacrolimus metabolites 2024 ·Pharmacological Research ·(unknown), (unknown), François‐Ludovic Sauvage, (unknown), Émilie Pinault, (unknown), Gildas Bertho, Nicolas Giraud, Rodolphe Alves de Sousa, Adolfo López‐Noriega, Florent Di Meo, (unknown), Pierre Marquet	1
6	Tacrolimus Dose Requirement in De Novo Adult Kidney Transplant Patients Treated With Adoport® Can Be Anticipated 2024 ·Transplant International ·Pierre Marquet, Dany Anglicheau, (unknown), (unknown), (unknown), (unknown), (unknown), Audrey Lardy-Cléaud, (unknown)	1
7	Characterizing microstructures with representative tortuosities 2024 ·SHILAP Revista de lepidopterología ·(unknown), Maxime Moreaud, Loïc Sorbier, Pierre Marquet, (unknown), Thierry Fournel	1
8	Active or passive maternal smoking increases the risk of low birth weight or preterm delivery: Benefits of cessation and tobacco control policies 2023 ·Tobacco Induced Diseases ·(unknown), (unknown), Pierre Marquet, Tristan Gauthier, Daniel Thomas, Y. Aubard	13
9	Semi-synthetic human albumin isoforms: Production, structure, binding capacities and influence on a routine laboratory test 2023 ·International Journal of Biological Macromolecules ·(unknown), François‐Ludovic Sauvage, Émilie Pinault, Pierre Marquet, Franck Saint‐Marcoux, Souleiman El Balkhi	1
10	New perspectives for the therapeutic drug monitoring of tacrolimus: Quantification in volumetric DBS based on an automated extraction and LC-MS/MS analysis 2023 ·Journal of Chromatography B ·(unknown), (unknown), Souleiman El Balkhi, Jean-Philippe Rérolle, Marilyne Debette‐Gratien, Pierre Marquet, Franck Saint‐Marcoux, Caroline Monchaud	11
11	Tacrolimus population pharmacokinetics in adult heart transplant patients 2023 ·British Journal of Clinical Pharmacology ·(unknown), Alexandre Destère, Caroline Monchaud, Marc Labriffe, Pierre Marquet, Jean‐Baptiste Woillard	6
12	Perfusate Metabolomics Content and Expression of Tubular Transporters During Human Kidney Graft Preservation by Hypothermic Machine Perfusion 2022 ·Transplantation ·(unknown), (unknown), François‐Ludovic Sauvage, Lionel Forestier, Elodie Miquelestorena‐Standley, Lydie Nadal‐Desbarats, (unknown), (unknown), N. Brichart, F. Bruyère, Pierre Marquet, Chantal Barin‐Le Guellec	7
13	Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes 2022 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), Chantal Barin‐Le Guellec, Pierre Marquet, Florent Di Meo	10
14	Machine learning-supported interpretation of kidney graft elementary lesions in combination with clinical data 2022 ·American Journal of Transplantation ·Marc Labriffe, Jean‐Baptiste Woillard, Wilfried Gwinner, (unknown), Dany Anglicheau, Marion Rabant, Priyanka Koshy, Maarten Naesens, Pierre Marquet	19
15	Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection 2020 ·American Journal of Transplantation ·Claire Tinel, Arnaud Devresse, (unknown), Virginia Sauvaget, David Marx, Véronique Avettand-Fènoël, Lucile Amrouche, Marc‐Olivier Timsit, Renaud Snanoudj, Sophie Caillard, Bruno Moulin, Jérôme Olagne, Marie Essig, Wilfried Gwinner, Maarten Naesens, Pierre Marquet, Christophe Legendre, Fabiola Terzi, Marion Rabant, Dany Anglicheau	50
16	Sum of peak intensities outperforms peak area integration in iTRAQ protein expression measurement by LC-MS/MS using a TripleTOF 5600+ platform 2019 ·Bioscience Reports ·(unknown), Julien Gonzalez, François‐Ludovic Sauvage, (unknown), (unknown), Émilie Pinault, Pierre Marquet, Marie Essig	6
17	Image-Based Marker-Free Screening of GABAA Agonists, Antagonists, and Modulators 2019 ·SLAS DISCOVERY ·Benjamin Rappaz, Pascal Jourdain, Damiano Banfi, Fabien Kuttler, Pierre Marquet, Gerardo Turcatti	4
18	Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data. 2016 ·PubMed ·Nadia Ben Fredj, Jean‐Baptiste Woillard, Jean Debord, Amel Chaabane, Naceur A. Boughattas, Pierre Marquet, Franck Saint‐Marcoux, Karim Aouam	8
19	Stability of Ribavirin Concentrations Depending on the Type of Blood Collection Tube and Preanalytical Conditions 2010 ·Therapeutic Drug Monitoring ·Pierre Marquet, François‐Ludovic Sauvage, V. Loustaud‐Ratti, G Babany, Annick Rousseau, Gérard Lachâtre	9
20	Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference 2009 ·Therapeutic Drug Monitoring ·Pierre Wallemacq, Victor W. Armstrong, Merçè Brunet, Vincent Haufroid, David W. Holt, A. E. Johnston, Dirk Kuypers, Yannick Le Meur, Pierre Marquet, Michael Oellerich, Éric Thervet, (unknown), N. Undre, Lutz T. Weber, Ian S Westley, Michel Mourad	362

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact